BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 15601779)

  • 1. Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I.
    Kedar V; McDonough H; Arya R; Li HH; Rockman HA; Patterson C
    Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18135-40. PubMed ID: 15601779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBE2D2 is not involved in MuRF1-dependent muscle wasting during hindlimb suspension.
    Polge C; Koulmann N; Claustre A; Jarzaguet M; Serrurier B; Combaret L; Béchet D; Bigard X; Attaix D; Taillandier D
    Int J Biochem Cell Biol; 2016 Oct; 79():488-493. PubMed ID: 27378730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle.
    Clarke BA; Drujan D; Willis MS; Murphy LO; Corpina RA; Burova E; Rakhilin SV; Stitt TN; Patterson C; Latres E; Glass DJ
    Cell Metab; 2007 Nov; 6(5):376-85. PubMed ID: 17983583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the ubiquitin E3 ligase MuRF1 to inhibit muscle atrophy.
    Eddins MJ; Marblestone JG; Suresh Kumar KG; Leach CA; Sterner DE; Mattern MR; Nicholson B
    Cell Biochem Biophys; 2011 Jun; 60(1-2):113-8. PubMed ID: 21448668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac proteasome activity in muscle ring finger-1 null mice at rest and following synthetic glucocorticoid treatment.
    Hwee DT; Gomes AV; Bodine SC
    Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E967-77. PubMed ID: 21828340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of large conductance Ca2+-activated K+ (BK) channel β1 subunit expression by muscle RING finger protein 1 in diabetic vessels.
    Yi F; Wang H; Chai Q; Wang X; Shen WK; Willis MS; Lee HC; Lu T
    J Biol Chem; 2014 Apr; 289(15):10853-10864. PubMed ID: 24570002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DCAF8, a novel MuRF1 interaction partner, promotes muscle atrophy.
    Nowak M; Suenkel B; Porras P; Migotti R; Schmidt F; Kny M; Zhu X; Wanker EE; Dittmar G; Fielitz J; Sommer T
    J Cell Sci; 2019 Sep; 132(17):. PubMed ID: 31391242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin ligase MuRF1 protects against cardiac ischemia/reperfusion injury by its proteasome-dependent degradation of phospho-c-Jun.
    Li HH; Du J; Fan YN; Zhang ML; Liu DP; Li L; Lockyer P; Kang EY; Patterson C; Willis MS
    Am J Pathol; 2011 Mar; 178(3):1043-58. PubMed ID: 21356357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressed expression of MuRF1 and MAFbx in areas remote of recent myocardial infarction: a mechanism contributing to myocardial remodeling?
    Conraads VM; Vrints CJ; Rodrigus IE; Hoymans VY; Van Craenenbroeck EM; Bosmans J; Claeys MJ; Van Herck P; Linke A; Schuler G; Adams V
    Basic Res Cardiol; 2010 Mar; 105(2):219-26. PubMed ID: 19859778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia.
    Bowen TS; Adams V; Werner S; Fischer T; Vinke P; Brogger MN; Mangner N; Linke A; Sehr P; Lewis J; Labeit D; Gasch A; Labeit S
    J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):939-953. PubMed ID: 28887874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of MuRF1 is essential for TNF-alpha-induced loss of muscle function in mice.
    Adams V; Mangner N; Gasch A; Krohne C; Gielen S; Hirner S; Thierse HJ; Witt CC; Linke A; Schuler G; Labeit S
    J Mol Biol; 2008 Dec; 384(1):48-59. PubMed ID: 18804115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MuRF1 mono-ubiquitinates TRα to inhibit T3-induced cardiac hypertrophy in vivo.
    Wadosky KM; Berthiaume JM; Tang W; Zungu M; Portman MA; Gerdes AM; Willis MS
    J Mol Endocrinol; 2016 Apr; 56(3):273-90. PubMed ID: 26862156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms.
    Mearini G; Gedicke C; Schlossarek S; Witt CC; Krämer E; Cao P; Gomes MD; Lecker SH; Labeit S; Willis MS; Eschenhagen T; Carrier L
    Cardiovasc Res; 2010 Jan; 85(2):357-66. PubMed ID: 19850579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle ring finger 1 and muscle ring finger 2 are necessary but functionally redundant during developmental cardiac growth and regulate E2F1-mediated gene expression in vivo.
    Willis MS; Wadosky KM; Rodríguez JE; Schisler JC; Lockyer P; Hilliard EG; Glass DJ; Patterson C
    Cell Biochem Funct; 2014 Jan; 32(1):39-50. PubMed ID: 23512667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.
    Maejima Y; Usui S; Zhai P; Takamura M; Kaneko S; Zablocki D; Yokota M; Isobe M; Sadoshima J
    Circ Heart Fail; 2014 May; 7(3):479-90. PubMed ID: 24526353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin Exposure Causes Subacute Cardiac Atrophy Dependent on the Striated Muscle-Specific Ubiquitin Ligase MuRF1.
    Willis MS; Parry TL; Brown DI; Mota RI; Huang W; Beak JY; Sola M; Zhou C; Hicks ST; Caughey MC; D'Agostino RB; Jordan J; Hundley WG; Jensen BC
    Circ Heart Fail; 2019 Mar; 12(3):e005234. PubMed ID: 30871347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMP-activated protein kinase regulates E3 ligases in rodent heart.
    Baskin KK; Taegtmeyer H
    Circ Res; 2011 Oct; 109(10):1153-61. PubMed ID: 21921267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle RING-finger protein-1 (MuRF1) as a connector of muscle energy metabolism and protein synthesis.
    Koyama S; Hata S; Witt CC; Ono Y; Lerche S; Ojima K; Chiba T; Doi N; Kitamura F; Tanaka K; Abe K; Witt SH; Rybin V; Gasch A; Franz T; Labeit S; Sorimachi H
    J Mol Biol; 2008 Mar; 376(5):1224-36. PubMed ID: 18222470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1.
    Parry TL; Desai G; Schisler JC; Li L; Quintana MT; Stanley N; Lockyer P; Patterson C; Willis MS
    Cardiovasc Pathol; 2016; 25(2):127-140. PubMed ID: 26764147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells.
    Krawiec BJ; Nystrom GJ; Frost RA; Jefferson LS; Lang CH
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1555-67. PubMed ID: 17264220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.